4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-038761
Executive VP, Head of R&D sold 7,158 shares at an average $75.04 ($537,123)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Tony W Executive VP, Head of R&D | 2020-06-22 | Sale | −229 | $70.14 | $16,062 | 40,676 | D |
| Ho Tony W Executive VP, Head of R&D | 2020-06-23 | Sale | −6,929 | $75.20 | $521,061 | 33,747 | D |
| Open-market sales · 7,158 sh · avg $75.04 · $537,123 | |||||||
Loading xslF345X03/doc4.xml…